Search Results - "Kaliberov, Sergey A."

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression by Kaliberova, Lyudmila N, Kusmartsev, Sergei A, Krendelchtchikova, Valentina, Stockard, Cecil R, Grizzle, William E, Buchsbaum, Donald J, Kaliberov, Sergey A

    Published in Molecular cancer therapeutics (01-11-2009)
    “…Preclinical and clinical evidence shows that cyclooxygenase-2 (Cox-2)-mediated prostaglandin E 2 (PGE 2 ) overexpression plays an important role in tumor…”
    Get full text
    Journal Article
  2. 2

    Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein by van Erp, Elisabeth A, Kaliberova, Lyudmila N, Kaliberov, Sergey A, Curiel, David T

    Published in Molecular therapy. Oncolytics (2015)
    “…Conditionally replicative adenoviruses are promising agents for oncolytic virotherapy. Various approaches have been attempted to retarget adenoviruses to…”
    Get full text
    Journal Article
  3. 3

    Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene by Kaliberova, Lyudmila N, Della Manna, Debbie L, Krendelchtchikova, Valentina, Black, Margaret E, Buchsbaum, Donald J, Kaliberov, Sergey A

    Published in Molecular cancer therapeutics (01-09-2008)
    “…The combination of molecular chemotherapy with radiation therapy has the potential to become a powerful approach for treatment of pancreatic cancer. We have…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Development of an adenovirus vector vaccine platform for targeting dendritic cells by Sharma, Piyush K., Dmitriev, Igor P., Kashentseva, Elena A., Raes, Geert, Li, Lijin, Kim, Samuel W., Lu, Zhi-Hong, Arbeit, Jeffrey M., Fleming, Timothy P., Kaliberov, Sergey A., Goedegebuure, S. Peter, Curiel, David T., Gillanders, William E.

    Published in Cancer gene therapy (01-02-2018)
    “…Adenoviral (Ad) vector vaccines represent one of the most promising modern vaccine platforms, and Ad vector vaccines are currently being investigated in human…”
    Get full text
    Journal Article
  6. 6

    Adenoviral targeting using genetically incorporated camelid single variable domains by Kaliberov, Sergey A, Kaliberova, Lyudmila N, Buggio, Maurizio, Tremblay, Jacqueline M, Shoemaker, Charles B, Curiel, David T

    Published in Laboratory investigation (01-08-2014)
    “…The unique ability of human adenovirus serotype 5 (Ad5) to accomplish efficient transduction has allowed the use of Ad5-based vectors for a range of gene…”
    Get full text
    Journal Article
  7. 7

    Retargeting of gene expression using endothelium specific hexon modified adenoviral vector by Kaliberov, Sergey A, Kaliberova, Lyudmila N, Hong Lu, Zhi, Preuss, Meredith A, Barnes, Justin A, Stockard, Cecil R, Grizzle, William E, Arbeit, Jeffrey M, Curiel, David T

    Published in Virology (New York, N.Y.) (01-12-2013)
    “…Abstract Adenovirus serotype 5 (Ad5) vectors are well suited for gene therapy. However, tissue-selective transduction by systemically administered Ad5-based…”
    Get full text
    Journal Article
  8. 8

    Gene delivery and gene therapy of prostate cancer by Kaliberov, Sergey A, Buchsbaum, Donald J

    Published in Expert opinion on drug delivery (01-01-2006)
    “…Surgery, radiation or hormonal therapy are not adequate to control prostate cancer. Clearly, other novel treatment approaches, such as gene therapy, for…”
    Get more information
    Journal Article
  9. 9

    Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer by Kaliberov, Sergey A, Kaliberova, Lyudmila N, Stockard, Cecil R, Grizzle, William E, Buchsbaum, Donald J

    Published in Molecular therapy (01-12-2004)
    “…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) is of particular interest in the development of prostate carcinoma therapeutics as it…”
    Get full text
    Journal Article
  10. 10

    Adenovirus-Mediated Transfer of BAX Driven by the Vascular Endothelial Growth Factor Promoter Induces Apoptosis in Lung Cancer Cells by Kaliberov, Sergey A, Buchsbaum, Donald J, Gillespie, G.Yancey, Curiel, David T, Arafat, Waleed O, Carpenter, Mark, Stackhouse, Murray A

    Published in Molecular therapy (01-08-2002)
    “…Apoptosis induction is a promising approach for cancer gene therapy. Bax is a death-promoting member of the Bcl2 family of genes that are intimately involved…”
    Get full text
    Journal Article
  11. 11

    947. Gene Directed Enzyme/Prodrug Therapy of Human Glioma Xenografts Using Mutant Escherichia coli Cytosine Deaminase by Kaliberov, Sergey A., Krendelchtchikova, Valentina, Manna, Debbie Della, Sellers, Jeffrey C., Kaliberova, Lyudmila N., Black, Margaret E., Buchsbaum, Donald J.

    Published in Molecular therapy (01-05-2006)
    “…Combined treatment using suicide gene therapy and radiation therapy has the potential to become a powerful new method of cancer therapy. We have developed a…”
    Get full text
    Journal Article
  12. 12

    Cancer Treatment with Gene Therapy and Radiation Therapy by Kaliberov, Sergey A., Buchsbaum, Donald J.

    Published in Advances in Cancer Research (2012)
    “…Radiation therapy methods have evolved remarkably in recent years which have resulted in more effective local tumor control with negligible toxicity of…”
    Get full text
    Book Chapter Journal Article
  13. 13

    Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus by Kaliberov, S A, Kaliberova, L N, Buchsbaum, D J, Curiel, D T

    Published in Cancer gene therapy (01-07-2014)
    “…Pancreatic cancer is a significant clinical problem and novel therapeutic approaches are desperately needed. Recent advances in conditionally replicative…”
    Get full text
    Journal Article
  14. 14

    Chapter seven--Cancer treatment with gene therapy and radiation therapy by Kaliberov, Sergey A, Buchsbaum, Donald J

    Published in Advances in cancer research (2012)
    “…Radiation therapy methods have evolved remarkably in recent years which have resulted in more effective local tumor control with negligible toxicity of…”
    Get full text
    Journal Article